CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C01204 | BRD-A50287893 | BRD-A50287893 | -- | -- | -- | Details |
| C01205 | BRD-A50310035 | misoprostol | PTGER2; PTGER3; PTGER4 | Prostanoid receptor agonist | -- | Details |
| C01206 | BRD-A50311610 | meclizine | NR1I3 | CAR agonist | meclozine | Details |
| C01207 | BRD-A50364343 | veliparib | PARP2; PARP1 | PARP inhibitor | -- | Details |
| C01208 | BRD-A50388635 | BRD-A50388635 | -- | -- | -- | Details |
| C01209 | BRD-A50454580 | PD-0325901 | MAP2K1 | MEK inhibitor; MAP kinase inhibitor; Protein kinase inhibitor | -- | Details |
| C01210 | BRD-A50590638 | BRD-A50590638 | -- | -- | -- | Details |
| C01211 | BRD-A50675702 | fipronil | -- | -- | -- | Details |
| C01212 | BRD-A50684349 | fenoldopam | DRD1 | Dopamine receptor agonist | -- | Details |
| C01213 | BRD-A50701104 | BRD-A50701104 | -- | -- | -- | Details |
| C01214 | BRD-A50737080 | CGK-733 | ATM; ATR | ATM kinase inhibitor; ATR kinase inhibitor | -- | Details |
| C01215 | BRD-A50764878 | MDL-73005EF | HTR1A | Serotonin receptor antagonist | -- | Details |
| C01216 | BRD-A50774520 | CVF-SUMO-11 | -- | -- | -- | Details |
| C01217 | BRD-A50796384 | NK26-I-41-1 | -- | -- | -- | Details |
| C01218 | BRD-A50837272 | BRD-A50837272 | -- | -- | -- | Details |
| C01219 | BRD-A50913845 | BRD-A50913845 | -- | -- | -- | Details |
| C01220 | BRD-A50928468 | norgestrel | -- | -- | -- | Details |
| C01221 | BRD-A50934474 | L-744832 | -- | -- | -- | Details |
| C01222 | BRD-A50984182 | JMV-431 | -- | -- | -- | Details |
| C01223 | BRD-A50998626 | palomid-529 | MTOR | Akt inhibitor; MTOR inhibitor; VEGFR inhibitor; Fibroblast growth factor inhibitor | PALOMID-529 | Details |
| C01224 | BRD-A51078674 | diclofensine | DRD1; MAOA; MAOB | Dopamine reuptake inhibitor | -- | Details |
| C01225 | BRD-A51182606 | BRD-A51182606 | -- | -- | chloramphenicol | Details |
| C01226 | BRD-A51233382 | tribenoside | -- | -- | -- | Details |
| C01227 | BRD-A51294525 | cyproterone | AR | Androgen receptor antagonist | -- | Details |
| C01228 | BRD-A51381734 | BRD-A51381734 | -- | -- | -- | Details |
| C01229 | BRD-A51382177 | fosinopril | ACE | Angiotensin converting enzyme inhibitor | -- | Details |
| C01230 | BRD-A51393488 | noscapine | SIGMAR1 | Tubulin inhibitor; Bradykinin receptor antagonist | -- | Details |
| C01231 | BRD-A51410489 | yohimbine | ADRA2A; ADRA2B; ADRA2C; HTR1A; HTR1B; HTR1D; HTR2B | Adrenergic receptor antagonist | -- | Details |
| C01232 | BRD-A51540388 | BRD-A51540388 | -- | -- | -- | Details |
| C01233 | BRD-A51571244 | hypoestoxide | IKBKB; IL1B; TNF | IKK inhibitor | -- | Details |
| C01234 | BRD-A51666293 | BRD-A51666293 | -- | -- | -- | Details |
| C01235 | BRD-A51696495 | KW-06 | -- | -- | -- | Details |
| C01236 | BRD-A51713165 | 3-CPMT | -- | -- | -- | Details |
| C01237 | BRD-A51714012 | venlafaxine | SLC6A2; SLC6A4 | Adrenergic inhibitor; Serotonin reuptake inhibitor; Norepinephrine reuptake inhibitor | -- | Details |
| C01238 | BRD-A51777634 | VU-0418933-1 | -- | -- | -- | Details |
| C01239 | BRD-A51820102 | econazole | -- | -- | -- | Details |
| C01240 | BRD-A51829654 | BRL-15572 | HTR1D | Serotonin receptor antagonist | -- | Details |
| C01241 | BRD-A51831848 | enflurane | GABRA1; GABRA2; GABRA3; GABRA4; GABRA5; GABRA6; GABRB1; GABRB2; GABRB3; GABRD; GABRE; GABRG1; GABRG2; GABRG3; GABRP; GLRA1; GLRB; GABRQ | Membrane permeability inhibitor | -- | Details |
| C01242 | BRD-A51916548 | BRD-A51916548 | -- | -- | norfenfluramine | Details |
| C01243 | BRD-A51929314 | BRD-A51929314 | -- | -- | -- | Details |
| C01244 | BRD-A51964809 | halofantrine | -- | -- | -- | Details |
| C01245 | BRD-A52024592 | BRD-A52024592 | -- | -- | -- | Details |
| C01246 | BRD-A52172093 | VU-0413807-2 | CACNA1I; CACNA1H; CACNA1G | Calcium channel blocker | -- | Details |
| C01247 | BRD-A52193669 | withaferin-a | NAMPT; IKBKB | IKK inhibitor | -- | Details |
| C01248 | BRD-A52252998 | clindamycin | -- | -- | -- | Details |
| C01249 | BRD-A52282606 | lacidipine | CACNA1C | Calcium channel blocker | -- | Details |
| C01250 | BRD-A52326238 | isogedunin | -- | -- | -- | Details |
| C01251 | BRD-A52377240 | BRD-A52377240 | -- | -- | -- | Details |
| C01252 | BRD-A52475911 | BRD-A52475911 | -- | -- | -- | Details |
| C01253 | BRD-A52510783 | BRD-A52510783 | -- | -- | -- | Details |
| C01254 | BRD-A52518985 | BRD-A52518985 | -- | -- | -- | Details |
| C01255 | BRD-A52530684 | doxorubicin | TOP2A | Topoisomerase inhibitor | -- | Details |
| C01256 | BRD-A52530852 | BRD-A52530852 | -- | -- | -- | Details |
| C01257 | BRD-A52588987 | SKF-83566 | -- | -- | -- | Details |
| C01258 | BRD-A52627843 | thiostrepton | FOXM1 | FOXM1 inhibitor; Protein synthesis inhibitor | -- | Details |
| C01259 | BRD-A52647795 | BRD-A52647795 | -- | -- | -- | Details |
| C01260 | BRD-A52650764 | ingenol | PRKCD; PRKCE | PKC activator | -- | Details |
| C01261 | BRD-A52660433 | tetrindole | MAOA | Monoamine oxidase inhibitor | -- | Details |
| C01262 | BRD-A52729710 | BRD-A52729710 | -- | -- | -- | Details |
| C01263 | BRD-A52749901 | BRD-A52749901 | -- | -- | -- | Details |
| C01264 | BRD-A52771319 | BRD-A52771319 | -- | -- | -- | Details |
| C01265 | BRD-A52794651 | BRD-A52794651 | -- | -- | -- | Details |
| C01266 | BRD-A52805806 | totaralolal | -- | -- | -- | Details |
| C01267 | BRD-A52886023 | antimycin-a | CYCS | ATP synthase inhibitor | -- | Details |
| C01268 | BRD-A52893269 | BRD-A52893269 | -- | -- | -- | Details |
| C01269 | BRD-A52922642 | gallopamil | -- | -- | -- | Details |
| C01270 | BRD-A52933579 | BRD-A52933579 | -- | -- | -- | Details |
| C01271 | BRD-A52934756 | BRD-A52934756 | -- | -- | 15-delta-prostaglandin-j2 | Details |
| C01272 | BRD-A52997285 | tetracycline | -- | -- | -- | Details |
| C01273 | BRD-A53077924 | tianeptine | OPRD1; OPRK1; OPRM1; SLC6A4 | Selective serotonin reuptake enhancer | -- | Details |
| C01274 | BRD-A53107311 | BRD-A53107311 | -- | -- | -- | Details |
| C01275 | BRD-A53131506 | BRD-A53131506 | -- | -- | epitestosterone | Details |
| C01276 | BRD-A53134341 | Ro-106-9920 | -- | -- | -- | Details |
| C01277 | BRD-A53176877 | methylprednisolone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C01278 | BRD-A53271750 | BRD-A53271750 | -- | -- | -- | Details |
| C01279 | BRD-A53381587 | BRD-A53381587 | -- | -- | -- | Details |
| C01280 | BRD-A53416814 | ceramide | -- | -- | -- | Details |
| C01281 | BRD-A53463743 | BRD-A53463743 | -- | -- | [2-(4-Nitro-phenyl)-quinazolin-4-yl]-(tetrahydro-furan-2-ylmethyl)-amine | Details |
| C01282 | BRD-A53561827 | pipenzolate | CHRM1 | Cholinergic receptor antagonist | -- | Details |
| C01283 | BRD-A53566267 | anecortave-acetate | -- | -- | -- | Details |
| C01284 | BRD-A53576514 | orphenadrine | -- | -- | -- | Details |
| C01285 | BRD-A53746180 | KM-04644SC | -- | -- | -- | Details |
| C01286 | BRD-A53850583 | BRD-A53850583 | -- | -- | -- | Details |
| C01287 | BRD-A53952395 | prilocaine | SCN5A | Local anesthetic | -- | Details |
| C01288 | BRD-A54024781 | BG-1008 | -- | -- | -- | Details |
| C01289 | BRD-A54029483 | IRL-2500 | EDNRB | Endothelin receptor antagonist | -- | Details |
| C01290 | BRD-A54077041 | BRD-A54077041 | -- | -- | -- | Details |
| C01291 | BRD-A54194844 | BRD-A54194844 | -- | -- | -- | Details |
| C01292 | BRD-A54236247 | racephedrine | -- | -- | ephedrine-(racemic) | Details |
| C01293 | BRD-A54347351 | BRD-A54347351 | -- | -- | -- | Details |
| C01294 | BRD-A54389315 | BRD-A54389315 | -- | -- | -- | Details |
| C01295 | BRD-A54393207 | dl-menthol | -- | -- | -- | Details |
| C01296 | BRD-A54445976 | napelline | -- | -- | -- | Details |
| C01297 | BRD-A54487287 | cortisone-acetate | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C01298 | BRD-A54490075 | BRD-A54490075 | -- | -- | -- | Details |
| C01299 | BRD-A54490543 | pirlindole | MAOA | Monoamine oxidase inhibitor | -- | Details |
| C01300 | BRD-A54493496 | ketamine | -- | -- | -- | Details |
| C01301 | BRD-A54537387 | cinchonidine | -- | -- | -- | Details |
| C01302 | BRD-A54574925 | BRD-A54574925 | -- | -- | -- | Details |
| C01303 | BRD-A54596827 | solifenacin | CHRM1; CHRM2; CHRM3 | Acetylcholine receptor antagonist | -- | Details |